Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2

The use of targeted inhibitors has shown promise as an effective approach in cancer therapy. However, targeted therapies based only on one drug, such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), have limited success, partly because cancer cells engage alternate pathways for survival and proli...

Descripció completa

Dades bibliogràfiques

Autors principals:	Todorović Lidija, Stamenković Gorana, Vučetić-Tadić Biljana, Umezawa Kazuo, Božović Ana, Yamashita Shunichi, Stanojević Boban
Format:	Artigo
Idioma:	Inglês
Publicat:	University of Belgrade, University of Novi Sad 2021-01-01
Col·lecció:	Archives of Biological Sciences
Matèries:	nf-κb inhibitor hsp90 inhibitor synergy targeted inhibitor combined treatment
Accés en línia:	http://www.doiserbia.nb.rs/img/doi/0354-4664/2021/0354-46642000055T.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!